Drugs / Infracyanine
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| — | NCT02875626 | Sep 2016 → Feb 2019 | breast cancer | Association Pour La Recherche des Thérapeutiques Innovantes en Cancérologie | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Infracyanine | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02875626 ↗ |
| Route | Other | “a periareolar injection of the Infracyanine will be carried out” NCT02875626 ↗ |